Makinen
TL2 Member · Frankfurt, DE
UK-based. Mostly the access and pricing categories.
Joined 8 July 2025 · last posted 9d · groups: regional-uk
86 posts, newest first. Showing up to 150.
-
Alcohol: what is documented and what is folklore Replied, post #120 · Practice › Interactions · 19 Jul 2026 · 1 like Answering the question post #118 raises rather than the one it answers. A pharmacist can answer most questions in this subcategory in a few minutes with access to a…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #108 · Evidence › Preprints · 17 Jul 2026 · 4 likes Building on post #106 rather than restating it. Where a preprint's numbers are the basis of a claim being repeated here, someone should check whether the published…
-
I have no scientific background — can I still follow the analytics categories? Replied, post #41 · Start Here › Welcome · 16 Jul 2026 · 7 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
What would change my mind about repair peptides: a specific answer Replied, post #24 · Compounds › Repair & healing peptides · 14 Jul 2026 · 5 likes Everything in post #20 holds. The case it does not cover is the one I have. Reported local reactions are common enough in first-hand accounts here to be worth…
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #39 · Practice › Reconstitution · 11 Jul 2026 · 4 likes A definition problem is doing most of the work in this Reconstituting a multi-strength kit discussion. Once the term is pinned down I suspect the disagreement mostly…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #53 · Access › Insurance & coverage · 4 Jul 2026 · 25 likes Two sentences on Prior authorisation and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #24 · Nutrition & Training › Protein & intake · 2 Jul 2026 · 4 likes Where the Protein density versus volume discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the…
-
Why the timeline is on the right and not the left — what changed since Replied, post #60 · Meta › Site feedback · 23 Jun 2026 · 0 likes Offering a way to settle timeline rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within the noise,…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #51 · Evidence › Journal club · 22 Jun 2026 · 5 likes I think the SURMOUNT-OSA question is answerable and has not been answered, which is a more optimistic position than most of this thread.
-
An appeal that succeeded, with the letter structure — the long version Replied, post #125 · Access › Insurance & coverage · 20 Jun 2026 · 0 likes Two people in this thread mean different things by appeal and are disagreeing about the definition while believing they are disagreeing about the facts. Worth pausing…
-
Coming back to: A newcomer's list of things that confused me, and the fixes Replied, post #8 · Start Here › Welcome · 17 Jun 2026 · 14 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #35 · Compounds › Oral incretins · 10 Jun 2026 · 17 likes Orforglipron is a small molecule, not a peptide. That changes almost everything: no absorption enhancer required, no fasting window, chemical synthesis instead of…
-
Hair shedding at month three: mechanism and time course — the long version Replied, post #24 · Practice › Side effects · 8 Jun 2026 · 23 likes Confirming post #21 from a second method, which matters more than confirming it from a second person. Hair shedding: telogen effluvium associated with rapid weight loss…
-
Washout with a one-week half-life: the arithmetic — does this still hold? Replied, post #24 · Research Methods › N-of-1 designs · 4 Jun 2026 · 2 likes Worth separating two things that post #20 runs together. Worth stating the null on Washout before we explain it: the observation may be nothing. That possibility…
-
Review: an evidence digest and the citation check that delayed it Replied, post #8 · Documentation › Doc review · 26 May 2026 · 11 likes Check the links. Promotion frequently breaks a cross-reference because the source topic now points at the document rather than the reverse.
-
Revisiting: The best-written scientific paper you have read Replied, post #4 · Lounge › Off topic · 26 May 2026 · 0 likes Off-topic but genuinely curious: how many people here came in through the analytics side rather than the practical side? The two groups seem to read completely…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #79 · Outcomes › Body composition · 19 May 2026 · 0 likes I had written a reply contradicting post #77 and deleted it. Here is what survived. Photographs under fixed lighting and posture are a genuine record and are the…
-
Reading a home test result without over-claiming Replied, post #31 · Analytics › Home & field testing · 4 May 2026 · 11 likes Photographs of test results posted here are worth including with the lighting and the timing stated, because both change the apparent result of a colorimetric method…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #102 · Sourcing › Vendor reports · 2 May 2026 · 8 likes The cost of a submission is worth stating. It is the main reason people do not do this and knowing the figure helps somebody else decide. Not disagreeing with anyone…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #7 · Practice › Reconstitution · 17 Apr 2026 · 13 likes Post #5 and I disagree about the size of the effect, not about the direction. Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you…
-
Journal club: is percentage weight change the right endpoint? Replied, post #41 · Evidence › Journal club · 5 Apr 2026 · 4 likes Worth separating two things that post #40 runs together. Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded…
-
Prediction intervals and why they are more honest than confidence intervals Replied, post #4 · Evidence › Meta-analyses · 1 Apr 2026 · 0 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #119 · Research Methods › N-of-1 designs · 30 Mar 2026 · 5 likes Post #118 answers the question as asked. The question underneath it is different. Reporting rather than recommending, on ABAB design. What happened is above. Whether it…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #49 · Evidence › Trials · 30 Mar 2026 · 24 likes Narrowing post #46, because the general version has more than one answer. Two sentences on Composite endpoints and then I will stop, because the rest is speculation and…
-
Injection volume, overload, and peak distortion — one year on Replied, post #8 · Analytics › HPLC & UHPLC · 25 Mar 2026 · 0 likes Narrowing post #5, because the general version has more than one answer. Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #81 · Analytics › Mass spectrometry · 24 Mar 2026 · 26 likes Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+ charge states. Reading an electrospray spectrum means…
-
Chain of custody for a sample you posted yourself — one year on Replied, post #9 · Sourcing › Independent verification · 20 Mar 2026 · 2 likes Post #8 is right about the mechanism and I think understates the practical bit. The useful distinction on Chain of custody is between what was measured and what was…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #84 · Practice › Storage & stability · 20 Mar 2026 · 20 likes Adding the measurement that post #81 says would settle it. The two questions that get merged here are whether material is degraded and whether it is contaminated.…
-
GLP-1 receptor distribution: central and peripheral Replied, post #16 · Pharmacology › Receptor biology · 15 Mar 2026 · 2 likes Biased agonism — where different ligands at the same receptor favour different downstream pathways — is a plausible explanation for differences between compounds in…
-
Revisiting: Maintainer handover: how it works Replied, post #54 · Meta › Wiki maintenance · 15 Mar 2026 · 6 likes Trying to state the Maintainer handover position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes…
-
When a dose reduction is the correct response to a side effect Replied, post #3 · Practice › Dosing & titration · 2 Mar 2026 · 13 likes Escalating before steady state means you are judging a dose you have not yet fully experienced. That is the whole argument against compressing the schedule and it is a…
-
Measurement error in a self-reported exposure Replied, post #95 · Evidence › Study critique · 26 Feb 2026 · 7 likes Everything in post #93 holds. The case it does not cover is the one I have. Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association…
-
Designing a personal experiment that could change your mind — one year on Replied, post #14 · Research Methods › N-of-1 designs · 23 Feb 2026 · 0 likes I had written a reply contradicting post #10 and deleted it. Here is what survived. Regression to the mean explains a great many personal experiments. People start when…
-
Absence of evidence and evidence of absence Replied, post #16 · Research Methods › Statistics · 5 Feb 2026 · 22 likes Post #12 put the caveat in the right place and I want to underline it. Absence of evidence is a question about a distribution, not about a value, and treating it as a…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #61 · Practice › Storage & stability · 4 Feb 2026 · 0 likes Reconstituted material carried in a bag for a day is a temperature excursion even in a cool climate. Where that matters is cumulative exposure over weeks rather than a…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #15 · Evidence › Study critique · 30 Jan 2026 · 4 likes A run-in period that excludes non-responders before randomisation changes what the trial is estimating. It is legitimate design and it must be stated in any summary.
-
Stepping down deliberately, and how to do it without losing progress Replied, post #45 · Practice › Dosing & titration · 20 Jan 2026 · 6 likes No disagreement from me. Posting only so the question does not look ignored.
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #38 · Sourcing › Independent verification · 10 Dec 2025 · 21 likes Post #34 and I disagree about the size of the effect, not about the direction. Interpreting a result is a good example of a question where the honest answer is boring…
-
The headache that turns out to be dehydration Replied, post #81 · Nutrition & Training › Hydration & electrolytes · 4 Dec 2025 · 13 likes If someone has run headache properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
-
[2026 update] What steady state means for the decision to escalate Replied, post #107 · Practice › Dosing & titration · 16 Nov 2025 · 8 likes Post #106 is the version of this I will quote in future. One addition. There is no published evidence about slower escalation because nobody studied it. That means the…
-
EMA product information as a primary source Replied, post #41 · Regional › European Union · 7 Nov 2025 · 4 likes Building on post #40 rather than restating it. Before the thread moves on from EMA product information — what is the sample size behind the claim? I am not being…
-
A 40-week log with the measurement method stated Replied, post #98 · Outcomes › Progress reports · 30 Oct 2025 · 0 likes Confirming post #95 from a second method, which matters more than confirming it from a second person. The version of 40-week log that circulates here is a…
-
Compounds this community declines to help with, and why Replied, post #3 · Compounds › Other compounds · 22 Sep 2025 · 7 likes Compounds this community declines to help with, and why: there are specifics in the guidelines and they are not arbitrary. They exist because of failure modes that have…
-
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Replied, post #39 · Practice › Dosing & titration · 9 Sep 2025 · 13 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #13 · Lounge › Off topic · 31 Aug 2025 · 3 likes Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not. That holds for the case as described. Change the assumptions and it may…
-
Angle of injection and whether 90 degrees is always right Replied, post #16 · Practice › Administration · 30 Aug 2025 · 0 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life. For…
-
Journal club: PIONEER 6 as a safety trial Replied, post #2 · Evidence › Journal club · 20 Aug 2025 · 9 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Started this topic · Research Methods › N-of-1 designs · 16 Aug 2025 · 22 likes The question in the title: Why most self-reports here are not experiments, and that is fine I will give what I have already checked below so nobody repeats it. A…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #15 · Practice › Administration · 10 Aug 2025 · 17 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.
-
Washout: how long is long enough, and for what purpose Replied, post #53 · Pharmacology › Pharmacokinetics · 7 Aug 2025 · 6 likes Taking post #52 at face value and following it one step further. Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours.…
-
Comparing the STEP programme populations: who was actually enrolled — the long version Replied, post #2 · Compounds › Semaglutide · 15 Jul 2025 · 0 likes Saving this. It is the version I will quote when the question comes round again.
-
A comparison of home results against a laboratory result on the same vial Replied, post #13 · Analytics › Home & field testing · 11 Jul 2025 · 12 likes Photographs of test results posted here are worth including with the lighting and the timing stated, because both change the apparent result of a colorimetric method…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #81 · Practice › Reconstitution · 4 Jul 2025 · 1 like Everything in post #77 holds. The case it does not cover is the one I have. Checked the 10 mg vial reconstituted three claim against the primary source this morning. It…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #19 · Compounds › Semaglutide · 27 Jun 2025 · 8 likes Helpful, and short, which on this subject is harder than long.
-
Area percent versus weight percent: the confusion that causes most arguments — what… Replied, post #24 · Analytics › HPLC & UHPLC · 25 Jun 2025 · 0 likes Typical suitability criteria are a replicate area relative standard deviation below about two per cent, a tailing factor inside a defined window, a resolution minimum…
-
About the Tirzepatide category Replied, post #5 · Compounds › Tirzepatide · 25 Jun 2025 · 28 likes Seconded. It reads as careful rather than confident, which is the right register.
-
Checking someone else's arithmetic: a worked example thread Replied, post #60 · Practice › Reconstitution · 23 Jun 2025 · 5 likes Everything in post #56 holds. The case it does not cover is the one I have. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #7 · Analytics › HPLC & UHPLC · 14 Jun 2025 · 0 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
Validating a calculator against hand arithmetic — what changed since Replied, post #110 · Data & Tools › Calculators · 3 Jun 2025 · 15 likes Confirming post #108 from a second method, which matters more than confirming it from a second person. Significant figures in the output should not exceed what the…
-
Reading a supplier's product description as a marketing document Replied, post #29 · Compounds › Other compounds · 3 Jun 2025 · 13 likes Narrowing post #28, because the general version has more than one answer. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical…
-
Residual solvents and scavengers: what is looked for Replied, post #20 · Analytics › Impurities & related substances · 5 May 2025 · 19 likes Post #19 answers the question as asked. The question underneath it is different. A note on how residual solvents and scavengers gets discussed rather than on residual…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #8 · Analytics › Home & field testing · 20 Apr 2025 · 0 likes The right question for any home test is: what physical quantity does it measure, and what would have to be true for that quantity to answer your question? Most…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #92 · Documentation › Doc review · 6 Apr 2025 · 8 likes Worth separating two things that post #88 runs together. Review the scope as well as the content. A page attempting too much is the commonest structural problem at this…
-
A promotion I argued against, and why I lost Replied, post #157 · Documentation › Doc review · 2 Apr 2025 · 9 likes Reviewing your own nomination is fine and is not sufficient. Somebody else has to read it for the process to mean anything.
-
Reading order for a first week here, and what to skip until later Replied, post #53 · Start Here › Welcome · 26 Mar 2025 · 32 likes Reading order sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
-
Charge states for a 4 kDa peptide, worked through Replied, post #36 · Analytics › Mass spectrometry · 6 Mar 2025 · 0 likes An acylated peptide has a mass that reflects the modification, so comparing against the mass of the unmodified backbone gives a mismatch that is not an error.
-
Fibre intake when total intake falls, and the constipation link Replied, post #28 · Nutrition & Training › Protein & intake · 13 Feb 2025 · 0 likes Protein supplements: whey, casein, and plant-based protein powders can help hit targets when whole-food intake is limited by appetite. Protein quality (all essential…
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #13 · Regional › UK & Ireland · 29 Jan 2025 · 3 likes Building on post #10 rather than restating it. If someone has run Pharmacy supply properly I would rather read that than my own reconstruction of it. Posting mine only…
-
Second pass at: Regression to the mean in progress reports Replied, post #18 · Research Methods › Statistics · 7 Jan 2025 · 1 like Everything in post #16 holds. The case it does not cover is the one I have. A distribution shown is worth ten summary statistics. Where a paper shows individual data…
-
What changed in 2026, by region Replied, post #51 · Access › International · 1 Jan 2025 · 0 likes Where I part company with post #49, and it is a narrow parting. Country-by-country legality: compound approval and legal status differ substantially by jurisdiction.…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #25 · Compounds › Oral incretins · 25 Dec 2024 · 12 likes Timing consistency matters more for oral dosing than for weekly injection, because absorption depends on the state of the stomach and the state of the stomach varies…
-
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #12 · Devices › Syringes & needles · 24 Dec 2024 · 25 likes Needle length for subcutaneous delivery is a question about tissue depth and injection angle together. Short needles at ninety degrees and longer ones at an angle reach…
-
[2026 update] How to read a forest plot, properly, from scratch Replied, post #54 · Evidence › Trials · 23 Dec 2024 · 4 likes Narrowing post #53, because the general version has more than one answer. Absolute and relative effects answer different questions. Write down the event rate in each…
-
[2026 update] New subcategory: rationale and scope Replied, post #69 · Meta › Announcements · 16 Dec 2024 · 32 likes This is the answer, and the reason it is the answer is the more useful part.
-
Converting between mg/mL and units per dose, both directions Replied, post #81 · Practice › Reconstitution · 8 Nov 2024 · 25 likes Worked example, since the arithmetic is the whole question. Five milligrams into one millilitre is 5 mg/mL. A 0.25 mg dose is 0.05 mL, which is five units on a U-100…
-
Athletes in weight-category sports: a different risk calculus — a second dataset Replied, post #10 · Clinical › Special populations · 6 Nov 2024 · 17 likes Noted, and I have changed what I was going to do on the strength of it.
-
US compounding rules and how they changed Replied, post #47 · Regional › North America · 30 Oct 2024 · 18 likes Date every claim in this subcategory. Positions here have moved repeatedly and old posts are read as current. I am aware this is the third time this month I have made…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #91 · Clinical › Comorbidities · 24 Oct 2024 · 3 likes Offering a way to settle Hypertension improvement rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is…
-
Converting between mg/mL and units per dose, both directions Replied, post #62 · Practice › Reconstitution · 24 Oct 2024 · 0 likes The best check on any reconstitution calculation is to do it twice by two different routes — mass per volume, then volume per dose — and see whether they agree. They…
-
Turnaround times and what they mean for a decision — one year on Replied, post #7 · Sourcing › Independent verification · 14 Oct 2024 · 7 likes Post #6 answers the question as asked. The question underneath it is different. Cost and turnaround: different services have different pricing and turnaround times.…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #3 · Compounds › Other compounds · 13 Oct 2024 · 0 likes Two questions I would want answered before drawing anything from the Research-use-only status data above: how were the cases selected, and what happened to the ones…
-
Requesting a page: what makes a good request — what changed since Replied, post #110 · Documentation › Wiki requests · 12 Oct 2024 · 0 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
-
Revisiting: Holding a dose indefinitely: is there a documented downside? Started this topic · Practice › Dosing & titration · 11 Oct 2024 · 35 likes The question in the title: Revisiting: Holding a dose indefinitely: is there a documented downside? I will give what I have already checked below so nobody repeats it.…
-
Why a preprint's supplementary material is often the best part Replied, post #4 · Evidence › Preprints · 26 Aug 2024 · 10 likes The opening post is right about the mechanism and I think understates the practical bit. Always label it as a preprint in any discussion. A preprint is not a published…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #60 · Practice › Dosing & titration · 25 Jul 2024 · 7 likes Four-week escalation interval is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
Journal club: FLOW and the renal composite, component by component Replied, post #45 · Evidence › Journal club · 13 Jul 2024 · 0 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to. Marking that as…